Presentation and Status in Health Basket
Presentation | Basket | Yarpa | Pharmasoft |
---|---|---|---|
Capsules 20 X 375 mg |
7539 | 13402 |
Dosage
For oral use.
Adults including the elderly: Dosage is based upon an initial daily dosage of 2250mg Carbocisteine in divided doses, reducing to 1500mg daily in divided doses when a satisfactory response is obtained e.g. two capsules/ lozenges
three times a day reducing to one capsule/ lozenge four times a day or for normal syrup 12ml three times a day reducing to 8ml three times a day.
Children: Mucolit 375 Capsules and Mucolit 375 honey-lemon flavor lozenges are not recommended for children. The normal daily dosage is 20mg-25/kg body weight in divided doses. It is recommended that this is achieved with Mucolit Syrup or Tiptipot Mucolit only.
Indications
Abnormal, viscid or inspissated mucous secretions in acute or chronic respiratory disease.
Contra-Indications
Known hypersensitivity, active peptic ulcer, first trimester of pregnancy.
Special Precautions
Discontinuing breastfeeding temporarily or withholding the drug while breastfeeding.
See package insert (OTC).
Side Effects
Rare reports of skin rashes and gastrointestinal bleeding.
See package insert (OTC).
Pregnancy and Lactation
Pregnancy
There are no available data on Carbocysteine use in pregnant women. No conclusions can be drawn regarding whether
or not Carbocysteine is safe for use during pregnancy. The use of Carbocysteine in pregnant women is not recommended, especially during the first trimester.
Breast-feeding
There are no available data on the presence of Carbocysteine in human milk, milk production, or the effects on the breastfed infant. No conclusions can be drawn regarding whether or not Carbocysteine is safe for use during breastfeeding. The use of Carbocysteine in breastfeeding women is not recommended.